Mass spectrometry analysis reveals the distinct reaction pathways of d(CpoxG) with a photoactivatable Pt(iv) anticancer prodrug

Abstract

The interactions between d(CpoxG) (oxG = 8-oxo-guanine), a major form of the oxidatively damaged CpG island motif, and a photoactivatable anticancer Pt(IV) prodrug, trans,trans,trans-[Pt(N3)2(OH)2(pyridine)2] (1), were investigated using electrospray ionization mass spectrometry (ESI-MS). Surprisingly, the primary MS analysis showed that the major photooxidative products were the platinum-free dinucleotides d(CpGh) (2a)/d(CpIa) (2b) (possibly a mixture of the two isomers) and d(CpDGh) (3), in which the guanine was oxidized to 5-guanidino-hydantoin (Gh) or iminoallantoin (Ia) and 5-guanidino-dehydrohydantoin (DGh), respectively. Moreover, two mono-platinated adducts, {[CpGh] + 1′}+ (4) and {[CpDGh] + 1′}+ (5) (1′ = [PtII(N3)(py)2]+), and three Pt-crosslinked dinucleotide adducts, {[CpGh]2 + 1′′}2+ (6), {[CpGh] + [CpDGh] + 1′′}2+ (7) and {[CpDGh]2 + 1′′}2+ (8) (1′′ = [PtII(py)2]2+), were observed as the main platinated adducts. Tandem mass spectrometry with collision induced dissociation (CID) demonstrated that 1′ bound at Gh or DGh in 4 and 5, while the inter-dinucleotide crosslinks by 1′′ between Ghs, Gh and DGh, or DGhs in 6, 7 and 8 were implicated. Unexpectedly, the proposed platinated d(CpoxG) adducts were not observed, indicating that oxG preferentially undergoes further oxidation by the reactive oxygen species released during the photodecomposition of complex 1 rather than coordination with the reduced Pt(II). These results revealed the greater complexity of the photo-interaction of complex 1 with d(CpoxG) than with d(CpG), with the implication that oxG-containing DNA, in particular, the oxidative CpG island, might play a vital role in the mechanism of action of photoactivatable Pt(IV) prodrugs, which merits further exploration.

Graphical abstract: Mass spectrometry analysis reveals the distinct reaction pathways of d(CpoxG) with a photoactivatable Pt(iv) anticancer prodrug

Supplementary files

Article information

Article type
Paper
Submitted
12 Jul 2025
Accepted
30 Aug 2025
First published
01 Sep 2025

Analyst, 2025, Advance Article

Mass spectrometry analysis reveals the distinct reaction pathways of d(CpoxG) with a photoactivatable Pt(IV) anticancer prodrug

J. Zhang, Z. Ma, J. Lin, W. Li, X. Wu, Y. Zhao, F. Wang and K. Wu, Analyst, 2025, Advance Article , DOI: 10.1039/D5AN00728C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements